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Biofilm causes hospital-associated infections on indwelling medical devices. In
Staphylococcus aureus, Biofilm formation is controlled by intricately coordinated network
of regulating systems, of which the ATP-dependent protease ClpP shows an inhibitory
effect. Here, we demonstrate that the inhibitory effect of ClpP on biofilm formation is
through Agr and the cell wall hydrolase Sle1. Biofilm formed by clpP mutant consists of
proteins and extracellular DNA (eDNA). The increase of the protein was, at least in part,
due to the reduced protease activity of the mutant, which was caused by the decreased
activity of agr. On the other hand, the increase of eDNA was due to increased cell lysis
caused by the higher level of Sle1. Indeed, as compared with wild type, the clpP mutant
excreted an increased level of eDNA, and showed higher sensitivity to Triton-induced
autolysis. The deletion of sle1 in the clpP mutant decreased the biofilm formation, the
level of eDNA, and the Triton-induced autolysis to wild-type levels. Despite the increased
biofilm formation capability, however, the clpP mutant showed significantly reduced
virulence in a murine model of subcutaneous foreign body infection, indicating that the
increased biofilm formation capability cannot compensate for the intrinsic functions of
ClpP during infection.
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INTRODUCTION
Bacteria biofilms are complex communities which have intrinsic resistance to host immune
defenses and antibiotic treatment (Paharik and Horswill, 2016). In the important human pathogen
Staphylococcus aureus, biofilm enables the bacterium to persist during infections on indwelling
medical devices, endocarditis, or chronic wound infections (Otto, 2013). Depending on its
constituents, staphylococcal biofilm can be polysaccharide intercellular adhesion (PIA)-dependent
or proteins/ extracellular DNA (eDNA)-dependent (McCarthy et al., 2015). PIA is synthesized by
Liu et al. ClpP Inhibits Biofilm Formation
the enzyme encoded by the icaADBC operon, and can be an
important component of the biofilm matrix (Cramton et al.,
1999; Gotz, 2002; Jefferson et al., 2004). However, several studies
have shown that S. aureus can form a biofilm by proteins and
eDNA without PIA-involvement (Toledo-Arana et al., 2005;
Rohde et al., 2007). For proteins, protein A (Spa), and the
fibronectin-binding proteins FnbpA and FnbpB, are known to
play an important role in the biofilm matrix formation (O’Neill
et al., 2008; Merino et al., 2009). In the PIA-independent biofilm,
extracellular DNA (eDNA) is also an important component
of biofilm matrix (Kiedrowski et al., 2011; Okshevsky and
Meyer, 2015). For example, secreted protease Esp inhibits biofilm
formation by cleaving murein hydrolase autolysin (Atl) and
preventing release of eDNA (Chen et al., 2013).
Biofilm formation in S. aureus is controlled by an intricate
network of regulatory systems. Rot (repressor of toxin)
contributes to biofilm formation by down-regulating secreted
proteases (Mootz et al., 2015). The accessory gene regulator
(Agr) is known to inhibit biofilm formation by up-regulating
extracellular proteases, an important contributor to the
dispersal of established biofilm (Boles and Horswill, 2008).
Sigma factor B (sigB) contributes to biofilm formation by
suppressing the expression of RNAIII, the effector molecule of
Agr, which, in turn, leads to decreased levels of extracellular
proteases (Lauderdale et al., 2009; Marti et al., 2010). Recently,
AraC-type transcriptional regulator, Rsp, was shown to
inhibit biofilm formation by repressing the expression
of biofilm-associated genes such as ica operon (Li et al.,
2015).
Another important biofilm regulatory system is the ATP-
dependent protease ClpP, the proteolytic subunit of Clp proteases
(Arnold and Langer, 2002; Dalbey et al., 2012). In Clp proteases,
the proteolytic chamber is formed by two hexameric rings
of ClpP subunits, whereas the ATPase function is provided
by Clp ATPases such as ClpB, ClpC, ClpL, and ClpX. The
ClpP proteolytic activity is reported to play a critical role on
virulence, stress response, and physiology in S. aureus (Frees
et al., 2004). In the S. aureus 8325-4 strain, while ATPases ClpX
and ClpC promote biofilm formation, ClpP represses it (Frees
et al., 2004). However, it is not known whether the biofilm
inhibitory effect of ClpP is universal, and, if so, how ClpP
does it.
In this study, we found that the biofilm inhibitory effect of
ClpP is conserved among different S. aureus strains. Moreover,
we further demonstrate that the inhibitory effect is, at least in
part, due to ClpP’s effect on the quorum sensing system Agr, and
the cell wall hydrolyzing enzyme Sle1.
MATERIALS AND METHODS
Ethics Statement
All animal experiments protocols were performed following the
Guide for the Care and Use of Laboratory Animals of the
Chinese Association for Laboratory Animal Sciences (CALAS)
and were approved by the ethics committee of Renji Hospital,
School of medicine, Shanghai Jiaotong University, Shanghai,
China.
Bacterial Strains, Plasmids and Culture
Conditions
All experiments were performed with S. aureus Newman (NM)
or USA300 as the wild-type strains. The bacterial strains and
plasmids used in this study are listed in Supplementary Table
1. Escherichia coli and S. aureus were grown in Luria-Bertani
(LB) broth and tryptic soy broth (TSB), respectively. However,
for transduction of plasmids, heart infusion broth (HIB)
supplemented with 5 mM CaCl2 was used. When necessary,
antibiotics were added to the growth media at the following
concentrations: ampicillin, 100 µg/ml; erythromycin, 10 µg/ml;
and chloramphenicol, 5 µg/ml.
Construction of Plasmids
To construct the plasmid for deleting the lytM, sle1, or agr genes
in Newman and USA300 strains, we used a ligation independent
cloning (LIC) method (Aslanidis and De Jong, 1990). First,
vector DNA was PCR-amplified from pKOR1 using the primers
P236/237 (Supplementary Table 2). One- kb DNA fragments,
upstream and downstream of lytM, sle1, or agr, were amplified
by PCR from the chromosomal DNA with the primer pairs
P596/597 and P598/599 (for lytM), P632/633, and P634/637 (for
sle1) or P19/20 and P21/22 (for agr) (Supplementary Table 2) and
PrimSTAR (Takara), a PCR enzyme with high fidelity. The PCR
products were treated with T4 DNA polymerase in the presence
of dCTP (vector) or dGTP (insert DNA) andmixed together. The
DNA mixture was used to transform E. coli DH5α. The resulting
plasmids, pKOR11lytM, pKOR11sle1, or pKOR11agr were
electroporated into S. aureus strain RN4220 and subsequently
transduced into NM or USA300 with 885. The deletion was
carried out as described previously (Bae and Schneewind, 2006).
To generate complement plasmids for clpP mutant strain,
First, vector DNA was PCR-amplified from pCL55 using the
primers P35/80, the clpP gene full length with its own promoter
was amplified with the primer pairs P2525/2526 (Supplementary
Table 2). The plasmid was constructed with LIC and the resulting
plasmid, pclpP, was electroporated into S. aureus strain RN4220
and then into NM1clpP with885.
To express Sle1 proteins in S. aureus, the gene sle1
was PCR-amplified with the following primer pairs: PL96/97
(Supplementary Table 2). The amplified fragments were digested
with either BamHI/SalI. Then they were inserted into the multi-
copy plasmid pOS1 under the control of its own promoter,
resulting in pOS1-Sle1-his. The plasmids were transformed into
E. coli DH5a, and then into S. aureus RN4220. Finally, the
plasmids were transduced by 885 into wild type and clpP
transposon mutants of S. aureus. The test strains in TSB
containing chloramphicol (10 µg/ml) were incubated until early
stationary growth phase (OD600 is around 2). The proteins were
detected by Western blot analysis with anti-His-tag antibody.
DNA Manipulation
Unless stated otherwise, all restriction enzymes and DNA
modification enzymes were purchased from New England
Biolabs. Plasmids and genomic DNA were extracted with
plasmid miniprep kit (Omega) according to the manufacturer’s
instruction. Plasmid DNA was introduced into E. coli by the
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method of Hanahan (Hanahan, 1983) and into S. aureus RN4220
by electroporation with a gene pulser (Bio-Rad). Subsequent
transduction of the plasmids into target strains of S. aureus was
carried out with8 85.
Real-Time Quantitative Reverse
Transcription-PCR (RT-PCR)
Cells in 3 ml TSB cultures were harvested at the stationary phase
(OD600 value of 2). Cells were disrupted by shaking with a Mini-
Beadbeater (Biospec Products) at maximum speed for 30 s. Tubes
were then incubated on ice for 5 min. Then, the suspension
was centrifuged. Total RNA isolation from the supernatant
was performed according to the manufacturer’s instructions
(Qiagen). After treatment using a TURBO DNA-freeTM kit
(Ambion), ∼1 µg of total RNA was reverse-transcribed with a
HieffTM first Strand cDNA Synthesis Super Mix for RT-PCR kit
(Yeasen Bio). The cDNA was used as a template for real-time
PCR using SYBR-green PCR reagents (Roche). Reactions were
performed in a MicroAmp Optical 96-well reaction plate using a
7,500 Sequence Detector (Applied Biosystems). Primers used are
listed in Supplementary Table 2. All RT-PCR experiments were
performed in triplicate, with gyrase B (gyrB) used as an internal
control.
Western Blot Hybridization
Western blot analysis of proteins was carried out as described
previously (Sun et al., 2011). The AgrA antibody was generated
by GLbiochem, China. The His-tag antibody was bought from
Yeasen Bio, China. All other antibodies were generated by
GenScript.
Semi-Quantitative Biofilm Assay
Semi-quantitative biofilm assays were performed as described in
our previous work (Liu et al., 2011). Briefly, overnight cultures
of S. aureus strains were diluted 1:100 into fresh TSB with
0.5% Glucose. The diluted cultures were pipetted into sterile
96-well flat-bottom tissue culture plates and incubated at 37◦C
for 24 h. Culture supernatants were gently removed, and wells
were washed with phosphate-buffered saline (PBS). The adherent
organisms at the bottom of the wells were fixed by Bouin fixative
over 1 h. Then the fixative was gently removed, wells were washed
with PBS and stained with 0.4% (wt/vol) crystal violet. Biofilm
formation was measured with a MicroELISA autoreader.
Biofilm Formation Using a BioFlux
Microfluidic Flow Cell System
The BioFlux 1000z microfluidic system (Fluxion Biosciences,
CA) was used to assess biofilm formation under flow conditions
as described (Benoit et al., 2010). To grow biofilms, the
microfluidic channels were primed with TSB supplemented with
0.5% glucose at 2 dynes/cm2 for 10 min. Each channel of a 48-
well plate was coated with 20% platelet-poor human plasma in
50 mM carbonate buffer, PH 9.6 and incubated for 24 h at 4◦C
before biofilm assays were set-up. The exponential cultures were
diluted 1:100 in TSB supplemented with 0.5% glucose. Bacterial
suspensions were seeded at 0.2 dyn/cm2 for 5 s in all channels.
The plate was then incubated at room temperature for 1 h to
allow cells to adhere. Excess inoculums were removed and 0.8 ml
of TSB supplemented with 0.5% glucose was added to the input
wells. Biofilms were grown at 37◦C with a flow of fresh media at a
constant shear of 0.15 dyn/cm2. Images were taken every 10min
for 24 h at 10×magnification under brightfield.
Extracellular (e) DNA in Culture
Supernatants
Cell cultures were grown to exponential phase. Culture
supernatants from strain wild-type and its derivatives were
filter sterilized, extracted with phenol-chloroform, and ethanol
precipitated. Precipitates were suspended in H2O. The volumes
of water were varied to compensate for slight differences in
OD600 of the initial cultures. The eDNAs were quantified
FIGURE 1 | ClpP, but not its ATPases, inhibits biofilm formation in S.
aureus. (A) Biofilm formation was determined in clpP mutant and
complement strains in comparison to Newman (WT) in vitro by
semi-quantitative biofilm assay. The density of crystal violet-stained biofilms
was measured at A570. Data were derived from three independent
experiments, with four replicates of each experiment. *p < 0.05 (vs. WT). The
bottom showed crystal staining for biofilm formation. (B) Newman (WT), clpP
mutant and complement strains were grown in TSB supplemented with 0.5%
glucose in flow cells pre-coated with human plasma at 0.15 dynes/cm2 shear
using a Biofulx 1000z instrument. Brightfield images depicting biofilm
accumulation after 24 h were captured at 10 × magnification and are
representative of at least three independent experiments. (C) ClpP chaperons
are not involved in biofilm formation individually. Biofilm formation was
determined in clpB, clpC, clpL, clpX, and clpP mutant in comparison to
Newman (WT) in vitro by semi-quantitative biofilm assay. The density of crystal
violet-stained biofilms was measured at A570. Data were derived from three
independent experiments, with four replicates of each experiment. *p < 0.05
(vs. WT). The bottom showed crystal staining for biofilm formation. (D) Biofilm
formation was determined in clpP mutant in comparison to USA300 and
ST59-11-775 WT strains in vitro by semi-quantitative biofilm assay. The
density of crystal violet-stained biofilms was measured at A570. Data were
derived from three independent experiments, with four replicates in each
experiment. *P < 0.05; ***P < 0.001 (vs. WT).
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using Nanodrop 2000 (Thermo Scientific) and visualized by
agarose gel.
Triton X-100 Induced Autolysis Assays
Bacterial cells were grown in TSB containing 1 M NaCl to the
exponential growth phase at 37◦C with shaking and then washed
and suspended in 0.05 M Tris-HCl buffer (pH 7.5) containing
0.1% Triton X-100 and were incubated at 30◦C with shaking.
The optical density was measured in intervals. Results were
normalized to an OD600 at time zero.
Zymographic Analysis
Cell cultures were grown to exponential phase, and normalized
by OD600. The normalized supernatants were filtered through
0.22 µM filter and concentrated with a Centricon 3 concentrator
(Millipore) at 4◦C according to the manufacturer’s instructions.
Concentrated supernatants were mixed with an equal volume of
Laemmli sample buffer, and 20 µl was separated by 12% SDS-
PAGE supplemented with 0.2% autoclaved S. aureus RN4220
cell (wt/vol) as a substrate. After electrophoresis, the gels were
washed four times with distilled water for 30 min at room
temperature, incubated in 25 mM Tris-HCl containing 1.25%
Triton X-100 (pH 8.0) at 37◦C for 4 h, and then stained with
methylene blue in 0.01% KOH(wt/vol), followed by destaining in
deionized water.
Animal Infection Model
A murine subcutaneous foreign body infection model was
performed as described by Pozzi et al. (2012). Briefly, 20 male
BALB/c mice were randomly and evenly divided into two groups
and infected with wild type or clpP mutant bacteria. One-
centimeter long silicon catheters (14 gauge) were implanted
subcutaneously on each side at the flank of each mouse. Bacterial
cells were grown in TSB to the exponential growth phase and
then washed with and suspended in phosphate buffered saline
(PBS) to OD600 = 1.0. S. aureus (10
8 CFU) were injected into
the catheter bed. After 7 days, the mice were sacrificed. Catheters
were aseptically removed and manipulated with the method
described previously except with a sonication time of 15 min
(Liu et al., 2011). Furthermore, peri-catheter tissue, liver, spleen,
kidneys were dissected, weighed, and homogenized in 1 ml PBS.
Then serial dilutions of the wash fluid were plated on TSA
blood plates, and the recovered S. aureus colonies were counted.
Bacteria present in blood were also quantitatively cultured on
TSA blood plates for CFU counting.
FIGURE 2 | Proteins and eDNA, but not PIA, are involved in biofilm formation by clpP mutant. Degradation of clpP mutant biofilms by various concentrations
of protease (A) and nuclease (B). Biofilm formation by clpP mutant was determined in vitro by semi-quantitative biofilm assay. Data were from three independent
experiments, with four replicates of each experiment. *P < 0.05; **P < 0.01; ***P < 0.001 (vs. WT). The bottom showed crystal staining for biofilm formation. (C) The
expression of the icaA/icaB/icaC genes were determined in samples prepared from stationary-phase (OD600 = 2) cells grown in TSB, using quantitative RT-PCR. The
wild-type (WT) and clpP mutant (clpP) strains were used for the assay. Data were derived from three biological repeats.
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FIGURE 3 | In clpP mutant strain, protease activity is reduced due to
the low Agr activity. The transcription of the agrA/agrC genes (A) and the
expression of AgrA (B) were determined in samples prepared from
stationary-phase (OD600 = 2) cells grown in TSB using quantitative RT-PCR
and Western blot. The wild-type (WT) and clpP mutant strains were used for
the assay. agr mutant strain was used as a negative control. Data were derived
from three biological repeats. ***P < 0.001 (vs. WT). LC, loading control. (C)
Relative protease levels detected in wild type, clpP, agr, and clpP/agr double
mutant strains grown in broth culture. Images show bacterial colonies and
zones of clearing caused by protease activity on milk agar plates (20 g/L
non-fat milk). *P < 0.05 (vs. WT).
Statistics
Statistical analysis was performed using Graph-Pad Prism,
version 5. Error bars in all graphs show the standard deviation
(± SD).
RESULTS
ClpP, but Not Its ATPases, Inhibits Biofilm
Formation in Staphylococcus aureus
ClpP has been reported to inhibit biofilm formation in the S.
aureus 8325-4 strain (Frees et al., 2004). To examine whether
the biofilm inhibitory effect is universal, we analyzed biofilm
formation of clpP mutant in the following three strains: S.
aureus Newman, a methicillin-sensitive strain (MSSA), USA300,
the predominant community-associated methicillin-resistant
strain (CA-MRSA) in the USA and ST59 11-775, the most
frequent lineage of community-associated infections in China
and adjacent Asian countries (Li et al., 2016). In all three strains,
clpP mutants showed enhanced biofilm formation (Figure 1),
indicating that the biofilm inhibitory effect of ClpP is likely to
be universal among S. aureus strains. When biofilm formation
was analyzed in the presence of shear stress (0.15 dynes/cm2),
which imitates blood flow in veins, the biofilm inhibitory effect
of ClpP was still observed (Figure 1B). On the other hand, the
mutants of Clp ATPases showed a wild-type level of biofilm
formation (Figure 1C), indicating that either the Clp ATPases are
not involved in the regulation of the biofilm formation or they
have redundant roles.
Proteins and eDNA Are the Main
Components of the Biofilm Formed by clpP
Mutant
In the staphylococcal biofilm, the three main components are
proteins, extracellular DNA (eDNA) and PIA (Paharik and
Horswill, 2016). To determine the main constituents of the
biofilm formed by the clpP mutant, we first added Proteinase K
or nuclease to the biofilm formed by the Newman clpP mutant.
As shown in Figures 2A,B, the biofilm was reduced by either
proteinase K or nuclease, indicating proteins and eDNA are the
main components of the biofilm formed by the clpPmutant.
The involvement of PIA in the biofilm formation by the clpP
mutant was assessed indirectly by comparing the transcriptional
levels of icaABC, the genes encoding PIA-synthesis enzymes in
wild type and clpPmutant. As shown in Figure 2C, the transcript
levels of icaABC were not significantly affected by the clpP
mutation, suggesting that PIA probably does not contribute to
the increased biofilm formation by the clpPmutant.
In Newman and USA300 Strain
Backgrounds, the clpP Mutation Lowers
the Activity of Agr, Resulting in Reduced
Protease Activity
In S. aureus, the quorum sensing two component system Agr
is known to suppress biofilm formation by up-regulating the
production of extracellular proteases (Boles and Horswill, 2008).
In the strain 8325-4, clpP mutation is known to reduce the
activity of Agr (Frees et al., 2003; Michel et al., 2006). Indeed,
the transcript levels of agrA and agrC were greatly reduced in the
clpP mutants of both NM and USA300 strains (Figure 3A). The
expression level of the response regulator AgrA was also greatly
reduced in the clpP mutants (Figure 3B), further confirming the
lower Agr activity in the clpP mutant. Finally, we observed that
the protease activity was significantly decreased by mutation in
either clpP or agr (Figure 3C), indicating that protease activity
was reduced due to low Agr activity in clpPmutant strain.
The Overproduction of the Cell Wall
Hydrolase Sle1 Is Responsible for the
Increased Release of eDNA
Next we decided to determine the origin of the eDNA in the
biofilm of the clpP mutant (Figure 2B). Since the release of
eDNA is likely due to autolysis of S. aureus cells, we focused
on staphylococcal cell wall hydrolases. Among either proven
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or putative cell wall hydrolases in S. aureus, LytM and Sle1
are known to be affected by ClpP. The transcription of lytM
was up-regulated in the clpP mutant of S. aureus 8325 strain
(Michel et al., 2006), whereas, in the S. aureus strains 8325-
4 and Newman, Sle1 was shown to bind to ClpPtrap, the
protease-deficient mutant of ClpP (Feng et al., 2013). Therefore,
we examined whether either LytM or Sle1 play a role in the
biofilm formation by the clpP mutant. As can be seen, while
the deletion of lytM in the clpP mutant did not decrease the
biofilm formation (clpP/lytM in Figure 4A), the sle1 deletion did
(clpP/sle1 in Figure 4A), indicating that sle1 is required for the
biofilm formation by the clpP mutant. Indeed, a higher level
of Sle1 was detected in the clpP mutant as compared with the
wild type (Figure 4B). However, the transcription of sle1 was
either not significantly affected or reduced in the clpP mutants
(Figure 4C). These results are consistent with the idea that the
precursor of Sle1 is a ClpP substrate (Feng et al., 2013). Finally, to
investigate whether the increased level of Sle1 leads to the release
FIGURE 4 | The overproduction of the cell wall hydrolase Sle1 is responsible for the increased release of eDNA. (A) Biofilm formation was determined in
sle1, lytM, clpP/sle1, clpP/lytM double mutant strains in comparison to NM strain (WT) in vitro by semi-quantitative biofilm assay. agr mutant strain was used as a
positive control. The density of crystal violet-stained biofilms was measured at 570 nm. Data were derived from three independent experiments, with four replicates of
each experiment. *P < 0.05; **P < 0.01 (vs. WT). (B) The expression of the Sle1 protein was determined in samples prepared from stationary-phase (OD600 = 2) cells
grown in TSB by Western blot. The wild-type (WT) and clpP mutant strains were used for the assay. Sle1-pellet, Sle1 protein detected in the cell pellets; Sle1-sup,
Sle1 protein detected in the supernatant by TCA precipitation; SrtA, Sortase A was used as a loading control. (C) The expression of the sle1 gene was determined in
samples prepared from stationary-phase (OD600 = 2) cells grown in TSB, using quantitative RT-PCR. The wild-type (WT) and clpP mutant strains were used for the
assay. Data were derived from three biological repeats. *P < 0.05 (vs. WT). (D) Agarose gel of isolated eDNAs. Culture supernatants from the wild-type (WT) and its
derivatives were filter sterilized, extracted with phenol-chloroform and ethanol precipitated. Precipitates were suspended in H2O normalized according to OD600 of the
initial cultures. Data were derived from three biological repeats. *P < 0.05(vs. WT).
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of more eDNA, we compared the amount of eDNA in culture
supernatants of the test strains. Indeed, the culture supernatant of
the clpP mutant contained a higher level of eDNA, as compared
with that of wild type strain (clpP in Figure 4D). However, the
level of eDNAwas restored to that of wild type by further deletion
of sle1 (clpP/sle1 in Figure 4D), strongly suggesting that the
increased level of Sle1 is responsible for the heightened release
of eDNA, leading to more robust biofilm formation of the clpP
mutant.
Sle1 Is Responsible for the Increased
Autolysis of the clpP Mutant
Sle1 is a peptidoglycan hydrolase, preferentially cleaving the
N-acetylmuramyl-L-Ala bonds in dimeric cross-bridges that
interlink the two murein strands in the peptidoglycan (Kajimura
et al., 2005). Therefore, it is likely that the increased amount
of eDNA in the culture supernatant of clpP mutant is due to
the heightened cell lysis. To examine this notion, we measured
autolysis activity of the test strains in the presence of Triton X-
100. Indeed, the clpP mutation increased the autolysis activity of
S. aureus Newman and USA300 (clpP in Figure 5A). Although
the further deletion of lytM did not affect the autolysis activity of
the clpPmutant (clpP vs. clpP/lytM in Figure 5A), the deletion of
sle1 greatly reduced the autolysis activity of the clpPmutant (clpP
vs. clpP/sle1 in Figure 5A). Zymography analysis showed that, in
the test conditions, the cell wall hydrolase activities are mostly
provided by the major autolysin Atl and Sle1, while the clpP
mutant produced a higher level of Atl compared to WT only in
USA300 strain. However, the clpPmutation specifically increases
the overall activity of Sle1 (clpP vs. clpP/sle1 in Figure 5B).
The Role of clpP in the Pathogenesis of S.
aureus Biofilm-Associated Infection
ClpP is required for pathogenesis in a systemic staphylococcal
infection as well as skin abscess infection (Frees et al., 2003;
Farrand et al., 2013), indicating that ClpP plays important roles
in S. aureus pathogenesis. Although the clpP mutant showed a
slight growth defect especially during early exponential phase,
the final cell density was similar to that of wild-type at lag
phase (Supplementary Figure 1). Because clpP mutant showed
FIGURE 5 | Sle1 is responsible for the increase autolysis of the clpP mutant. (A) Triton X-100 induced autolysis. The average of two independent experiments
were shown. (B) Zymogram of S. aureus murein hydrolase activity. Concentrated culture supernatants from the wild-type (WT) and its derivatives were run on 12%
acrylamide-SDS gels containing heat killed S. aureus RN4220 cells. Numbers to the left indicate the molecular weights of size standards. Dark bands indicate regions
of murein hydrolase activity. The arrows showed the activity of murein hydrolase Sle1.
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an increased biofilm formation, we asked whether the increased
biofilm formation can compensate the important virulence
contributions of ClpP. A murine model of subcutaneous foreign
body infection was used to investigate the impact of clpP on
biofilm-associated infection in vivo. Progression of disease was
measured by determining bacterial loads on implanted catheters
while dissemination of the bacteria was examined by detecting
bacterial loads on peri-tissues and organs. Wild type and the clpP
mutant showed similar bacterial loads in the infected animals
(Figure 6A). However, significantly higher number of bacteria
were found in peri-catheter tissue as well as blood, liver, spleen,
and kidneys in the animals infected by the wild-type strain, as
compared with the animals infected by the clpP mutant strain
(Figures 6B–F), indicating that ClpP plays a critical role in
the dissemination of S. aureus, and that the increased biofilm
formation capability cannot compensate the critical role played
by ClpP.
DISCUSSION
In S. aureus, biofilm is an important virulence determinant
in hospital-associated infections on indwelling medical devices
(Joo and Otto, 2012). Staphylococcal biofilm formation is
known to be controlled by multiple global regulators including
ClpP, the proteolytic component of the Clp proteolysis system.
However, it has not been elucidated how ClpP controls biofilm
formation (Frees et al., 2004). In this study, we provided
evidence that ClpP controls staphylococcal biofilm formation by
activating the Agr quorum sensing system, a negative regulator of
biofilm formation, and suppressing the expression of the murein
hydrolase Sle1 at a post-transcriptional level. Moreover, using a
murine model of subcutaneous foreign body infection, we also
demonstrated that, in the clpP mutant, the increased biofilm
formation cannot compensate the other critical ClpP functions
missing in the mutant.
The Agr quorum sensing system plays important roles in
staphylococcal virulence by suppressing the expression of surface
protein expression and activating the expression of secreted
proteins such as hemolysin and enzymes (Le and Otto, 2015). In
particular, the Agr system is known to promote the detachment
of biofilm by inducing the expression of the metalloprotease
Aur and the serine proteases SplABCDEF (Boles and Horswill,
2008). Therefore, it is likely that the reduced expression of
those proteins contributed to the decreased protease activity
(Figure 3C) and the increased biofilm formation (Figure 1).
FIGURE 6 | Catheter colonization and dissemination of NM and clpP mutant strains in a mouse device-related infection model. Implanted catheter
segments were injected with 1 × 108 bacteria and mice were sacrificed after 7 days. Colony forming units (CFU) per catheter (A), per g peri-catheter tissue (B), per ml
blood (C), per g liver (D), per g spleen (E), per g kidney (F) recovered from animals infected with wild type (NM) and clpP mutant strain. Statistical significance
(p-values) is indicated in the figure.
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FIGURE 7 | Working model of the mechanism of how ClpP inhibits
biofilm formation. In a wild type condition, the Clp protease system is
expected to degrade an unidentified negative regulator of Agr, resulting in Agr
activation, which will limit the presence of proteins and repress biofilm
formation. On the other hand, the Clp protease system degrades the
precursor of cell wall hydrolase Sle1, resulting in the suppression of cell
autolysis. The suppression of autolysis will decrease the release of eDNA and
repress the formation of staphylococcal biofilm.
Then how does ClpP activate the activity of Agr? ClpP is
a protease, and the degradation of either AgrA or AgrC
by ClpP would result in reduced, not increased, activity of
Agr. Therefore, it is likely that ClpP controls Agr indirectly,
possibly by degradation of a negative regulator of Agr. For
negative regulators of agr transcription, the DNA binding
protein SarX and the two component systems ArlSR and
SrrAB are known (Fournier et al., 2001; Yarwood et al.,
2001; Manna and Cheung, 2006). It is possible that one
of those negative regulators is degraded by ClpP. Further,
work will need to address whether any of those or hitherto
unknown regulators are involved in the ClpP-mediated Agr
activation.
Sle1 is a N-acetyl-muramyl-L-alanine amidase and plays an
important role in splitting daughter cells during cell division
(Kajimura et al., 2005). However, Sle1 does not appear to
affect autolysis of staphylococcal cells (Kajimura et al., 2005).
Indeed, in our study, deletion of sle1 did not significantly affect
autolysis, eDNA release, or biofilm formation (WT vs. sle1 in
Figures 4, 5A). In contrast, in clpP mutant background, the
deletion of sle1 abolished autolysis, eDNA release, and biofilm
formation (clpP vs. clpP/sle1 in Figures 4, 5A). It is likely that,
in the wild type cells, ClpP-mediated control of Sle1 limits
the Sle1 function only to daughter cell cleavage (Figure 4B).
However, in the clpP mutant, due to increased concentration
(Figure 4B), Sle1 seems to play not only in daughter cell
separation, but also autolysis of the cells (Figure 5A). Unlike
Sle1, LytM did not play any role in autolysis, eDNA release,
or biofilm formation regardless of the mutation in clpP (lytM
and clpP/lytM in Figures 4, 5A). LytM was initially suggested
to be a glycylglycine endopeptidase (Ramadurai and Jayaswal,
1997). However, purified LytM did not show any lytic activity
against S. aureus cells, and lytM deletion did not affect
cell wall lysis (Singh et al., 2010). In our study, although
the transcription of lytM was increased in the clpP mutant
(Supplementary Figure 2), further deletion of lytM in the
clpP mutant did not reduce biofilm formation or autolysis
of the clpP mutant (Figures 4A, 5A), suggesting that LytM
does not play a significant role in cell wall hydrolysis of S.
aureus.
In a previous study, ClpX, an ATP-binding partner for ClpP,
was shown to bind Sle1 (Feng et al., 2013). The inactivation
of the ClpXP protease increased the β-lactam resistance by
controlling cell wall metabolism through regulating Sle1 and Atl
in JE2 strain (Baek et al., 2014). However, mutation in clpX
did not significantly increase biofilm formation (Figure 1C),
indicating that either Sle1 is delivered to ClpP by other
ATPase partners or Sle1 overexpression alone is not sufficient
to increase biofilm formation in the presence of functional
Agr. On the other hand, although the mutation in agr greatly
reduced protease production (Figure 3C), its effect on biofilm
formation is not as significant as clpP mutation (Figure 4A),
demonstrating the critical contribution of Sle1 to the biofilm
formation. Since Sle1 is a secreted protein, it is likely that
the precursor of Sle1 (i.e., Sle1 with signal peptide) binds
to either ClpX or other Clp ATPase and is processed by
ClpP.
Figure 7 illustrates our current model of how ClpP represses
biofilm formation in S. aureus. In a wild type condition, the
Clp protease system is expected to degrade an unidentified
negative regulator of Agr and Sle1, resulting in Agr activation
and suppression of cell autolysis. The activated Agr and
suppression of autolysis will limit the presence of proteins
and eDNA and repress the formation of staphylococcal
biofilm.
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